Rana R. McKay

Also affiliated with UC San Diego Health System, University of California San Diego, Dana-Farber Cancer Institute, University of California San Diego Medical Center, Liverpool John Moores University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008724

Top 44%

0.427DataRank

Top 44%8 citations

Ahmed Bilal Khalid, Serena Rahme, Caiwei Zhong, Lucia Kwak, Marita Salame +28 more

Papers

Driven by 84 papers — median percentile 33. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02887

N/A

4.4DataRank · unranked

181 citations

Matthew I. Milowsky, Daniel P. Petrylak, Christopher Hoimes, Thomas W. Flaig, Nataliya Mar +20 more

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

Cancer(2020)10.1002/cncr.33328

N/A

3.1DataRank · unranked

113 citations

Matthew T. Campbell, Wanling Xie, Subrina Farah, Mehmet Asım Bilen, Andrew Schmidt +11 more

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

Genome Medicine(2021)10.1186/s13073-021-00969-w

N/A

1.9DataRank · unranked

90 citations

Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta +14 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab062

N/A

1.3DataRank · unranked

31 citations

P.T. Courtney, Isla P. Garraway, John Einck, Abhishek Kumar, Marı́a Elena Martı́nez +8 more

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

Molecular Oncology(2021)10.1002/1878-0261.12931

N/A

0.959DataRank · unranked

22 citations

Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino +16 more

A phase 2 study of berzosertib (M6620) in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5034

N/A

0.461DataRank · unranked

8 citations

Wanling Xie, Edmund Folefac, Daniel Lee, Mamta Parikh, David J. Einstein +12 more

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008724

Top 44%

0.427DataRank

Top 44%8 citations

Ahmed Bilal Khalid, Serena Rahme, Caiwei Zhong, Lucia Kwak, Marita Salame +28 more

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.20.440657

N/A

0.349DataRank · unranked

7 citations

Alexander T. M. Cheung, Jett Crowdis, Jake R. Conway, Sabrina Y. Camp, Stephanie A. Wankowicz +15 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Cancers(2022)10.3390/cancers14174334

N/A

0.269DataRank · unranked

5 citations

Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann +42 more

An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10565

Top 67%

0.175DataRank

Top 67%2 citations

Pankil Shah, Jeremy L. Warner, Gerald Batist, Christopher R. Friese, Elizabeth A. Griffiths +15 more

Background prostate tissue is quantitatively abnormal on MRI in patients with clinically significant prostate cancer

medRxiv(2022)10.1101/2022.10.12.22280855

N/A

0.165DataRank · unranked

2 citations

Roshan Karunamuni, Troy S. Hussain, Allison Y. Zhong, Karoline Kallis, D. Deondre +14 more

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

Translational Oncology(2023)10.1016/j.tranon.2023.101709

N/A

0.115DataRank · unranked

1 citations

Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel Hausrath +62 more

Phase III study of local or systemic therapy INtensification DIrected by PET in prostate CAncer patients with post-prostaTEctomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5098

N/A

0DataRank · unranked

3 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Daniel H. Shevrin +10 more

PET-directed local or systemic therapy intensification in prostate cancer patients with post-prostatectomy biochemical recurrence: A trial of the ECOG-ACRIN Cancer Research Group (EA8191).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps267

N/A

0DataRank · unranked

2 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Daniel H. Shevrin +10 more

Impact of equal access healthcare on race disparities in bladder cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.399

N/A

0DataRank · unranked

1 citations

Abhishek Kumar, Edmund M. Qiao, Daniel Cherry, Vinit Nalawade, A. Karim Kader +4 more

Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer

British Journal of Urology(2021)10.1111/bju.15603

N/A

0DataRank · unranked

5 citations

Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +42 more

Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6561

N/A

0DataRank · unranked

0 citations

Gowri Satyanarayana, Maheen Z. Abidi, Shailesh Advani, Pamela Egan, Arielle Elkrief +15 more

Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6563

N/A

0DataRank · unranked

0 citations

Pankil Shah, Andrew Schmidt, Ziad Bakouny, Dimitrios Farmakiotis, Maheen Z. Abidi +14 more

Impact of age on treatment response in men with prostate cancer treated with radiotherapy

BJUI Compass(2021)10.1002/bco2.132

N/A

0DataRank · unranked

5 citations

Tyler J. Nelson, Rana R. McKay, A. Karim Kader, J. Kellogg Parsons, John Einck +6 more

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

Journal of Clinical Investigation(2022)10.1172/jci161858

N/A

0DataRank · unranked

33 citations

Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh +34 more

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.06.001

N/A

0DataRank · unranked

28 citations

Rafee Talukder, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +47 more

Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.012

N/A

0DataRank · unranked

23 citations

Elio Adib, Nicole Weise, Catherine Curran, Tyler F. Stewart, Dory Freeman +9 more

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

The Lancet Healthy Longevity(2022)10.1016/s2666-7568(22)00009-5

N/A

0DataRank · unranked

22 citations

Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff‐Burchfield, Rachel Rosovsky +45 more

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac037

N/A

0DataRank · unranked

19 citations

Kyle T. Enriquez, Tianyi Sun, Elizabeth J. Klein, Maheen Z. Abidi, Shailesh Advani +52 more

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.42046

N/A

0DataRank · unranked

11 citations

Tianyi Sun, David D. Chism, Narjust Duma, Julie Fu, Na Tosha Gatson +87 more

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.08.006

N/A

0DataRank · unranked

9 citations

Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +49 more

SMART COVID Navigator, a Clinical Decision Support Tool for COVID-19 Treatment: Design and Development Study

Journal of Medical Internet Research(2021)10.2196/29279

N/A

0DataRank · unranked

9 citations

Catherine Del Vecchio Fitz, Laura B. Kleiman, Suresh K. Bhavnani, Chinmay Jani, Surbhi Shah +4 more

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

British Journal of Urology(2021)10.1111/bju.15324

N/A

0DataRank · unranked

28 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +41 more

A phase 2 study of bevacizumab, erlotinib, and atezolizumab in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) associated or sporadic papillary renal cell cancer (pRCC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4604

N/A

0DataRank · unranked

2 citations

Elad Sharon, Cheryl Ann Pickett-Gies, Lisa Mac, Julia C. Friend, Erin B. Purcell +14 more

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans

European Urology Open Science(2021)10.1016/j.euros.2021.05.009

N/A

0DataRank · unranked

35 citations

Daniel Cherry, P.T. Courtney, Vinit Nalawade, Nikhil V. Kotha, Paul Riviere +6 more

Randomized phase II trial of gemcitabine, avelumab and carboplatin versus no neoadjuvant therapy preceding surgery for cisplatin-ineligible muscle-invasive urothelial carcinoma (MIUC): SWOG GAP trial (S2011).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps591

N/A

0DataRank · unranked

1 citations

Melissa Plets, Michael A. Liss, Joshua J. Meeks, Daniel P. Petrylak, Suzanne Cole +9 more

Impact of selection bias on outcomes in veterans with muscle-invasive bladder cancer receiving bladder preserving trimodality therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.462

N/A

0DataRank · unranked

1 citations

Nikhil V. Kotha, Tyler J. Nelson, Daniel Cherry, Tyler F. Stewart, Rana R. McKay +2 more

DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.129

N/A

0DataRank · unranked

0 citations

Richard E. Green, Joseph J. Park, Olesia Kellezi, Clara Hwang, Pedro C. Barata +15 more

Single cell phenotyping of PDL1 and HLA1 on circulating tumor cells (CTC) in clear cell renal cell carcinoma (ccRCC) on systemic treatment with immunotherapy (IO) and vascular endothelial growth factor receptor tyrosine kinase inhibitors (TKI).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.381

N/A

0DataRank · unranked

0 citations

Matthew C. Mannino, Matthew L. Bootsma, Rory M. Bade, Meghan Wells, Jennifer L. Schehr +5 more

Post-acute sequelae of SARS-CoV-2 infection in patients with cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e18746

N/A

0DataRank · unranked

0 citations

David J. Pinato, Sanjay Mishra, Renée Maria Saliby, Clara Hwang, Shuchi Gulati +15 more

COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5508

N/A

0DataRank · unranked

0 citations

Lauren S. Prescott, Erika Ruíz‐García, Clara Hwang, Hannah Heilman, Rana R. McKay +13 more

Smoking and COVID-19 in patients with cancer: Novel analysis from CCC19 registry.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e18766

N/A

0DataRank · unranked

0 citations

Cassandra Hennessy, Grace L. Wilson, Vidhyalakshmi Ramesh, Clara Hwang, Joy Awosika +14 more

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer

Cell Reports(2021)10.1016/j.celrep.2021.109665

N/A

0DataRank · unranked

41 citations

Alexander T. M. Cheung, Jett Crowdis, Jake R. Conway, Sabrina Y. Camp, Stephanie A. Wankowicz +15 more

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels

Annals of Oncology(2023)10.1016/j.annonc.2023.06.001

N/A

0DataRank · unranked

67 citations

Marina N. Sharifi, Jamie M. Sperger, Yue Shi, Matti Annala, Matthew L. Bootsma +29 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0DataRank · unranked

56 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100445

N/A

0DataRank · unranked

39 citations

Chris Labaki, Ziad Bakouny, Chih–Yuan Hsu, Andrew Schmidt, Gilberto Lopes +39 more

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102018

N/A

0DataRank · unranked

26 citations

Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazlı Dizman +23 more

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US

Quality of Life Research(2023)10.1007/s11136-023-03468-0

N/A

0DataRank · unranked

9 citations

Natalie Slopen, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain, Pedro C. Barata +18 more

Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.09.004

N/A

0DataRank · unranked

8 citations

Leah Deshler, Nicole Weise, Ahmed Shabaik, Ithaar Derweesh, Aditya Bagrodia +4 more

COVID-19 vaccination and breakthrough infections in patients with cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.12.006

N/A

0DataRank · unranked

102 citations

Chris Labaki, Chih–Yuan Hsu, Ziad Bakouny, Nino Balanchivadze, Stephanie Berg +34 more

Randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.111

N/A

0DataRank · unranked

6 citations

Rana R. McKay, Mary‐Ellen Taplin, Nancy B. Davis, Paul Monk, Leonard J. Appleman +14 more

Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0241-3

N/A

0DataRank · unranked

14 citations

Sunil Patel, J. Kellogg Parsons, Rishi Deka, Abhishek Kumar, John Einck +8 more

Study EV-103 dose escalation/cohort A: Long-term outcome of enfortumab vedotin + pembrolizumab in first-line (1L) cisplatin-ineligible locally advanced or metastatic urothelial carcinoma (la/mUC) with nearly 4 years of follow-up.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4505

N/A

0DataRank · unranked

21 citations

Jonathan E. Rosenberg, Rana R. McKay, Thomas W. Flaig, Daniel P. Petrylak, Christopher Hoimes +14 more

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4604

N/A

0DataRank · unranked

21 citations

Theodore Karrison, Bradley A. McGregor, Pedro C. Barata, Himanshu Nagar, Chad Tang +10 more

A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4607

N/A

0DataRank · unranked

3 citations

Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Rouf Banday +15 more

A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5110

N/A

0DataRank · unranked

2 citations

Wanling Xie, Archana Ajmera, Arlene Araneta, Christina Jamieson, Edmund Folefac +14 more

Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.247

N/A

0DataRank · unranked

1 citations

Jamie M. Sperger, Marina N. Sharifi, Yue Shi, Charlotte N. Stahlfeld, Jennifer L. Schehr +9 more

Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5118

N/A

0DataRank · unranked

1 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Alicia K. Morgans +10 more

Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.tps402

N/A

0DataRank · unranked

0 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Alicia K. Morgans +10 more

BMX inhibition and HSD3B1-driven resistance in prostate cancer in the Maverick trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.144

N/A

0DataRank · unranked

0 citations

Rana R. McKay, Jake Vinson, Mike A. Royal, Joshua M. Lang, Eric A. Klein +12 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

A multi-center natural history study of precision-based genomics in prostate cancer (PC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5121

N/A

0DataRank · unranked

0 citations

Joaquı́n Mateo, Wassim Abida, Rana R. McKay, Bruce Montgomery, Rahul Aggarwal +5 more

Robustness of cancer microbiome signals over a broad range of methodological variation

Oncogene(2024)10.1038/s41388-024-02974-w

N/A

0DataRank · unranked

64 citations

Daniel McDonald, Evguenia Kopylova, Caitlin Guccione, Qiyun Zhu, George I. Austin +16 more

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Cancer Cell(2024)10.1016/j.ccell.2024.03.002

N/A

0DataRank · unranked

46 citations

Chris Labaki, Tejas Jammihal, Wanling Xie, Maxine Sun, Valisha Shah +19 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma

Journal of Clinical Investigation(2024)10.1172/jci176230

N/A

0DataRank · unranked

31 citations

Pedro C. Barata, Andrew Elliott, Mehmet Asım Bilen, Earle F. Burgess, Toni K. Choueiri +16 more

Pan-Cancer Interrogation of B7-H3 ( CD276 ) as an Actionable Therapeutic Target Across Human Malignancies

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0546

N/A

0DataRank · unranked

23 citations

John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich +18 more

Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration

Cancer(2020)10.1002/cncr.33224

N/A

0DataRank · unranked

50 citations

Reith Sarkar, Abhishek Kumar, John Einck, Isla P. Garraway, Julie A. Lynch +6 more

Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment

Molecules(2024)10.3390/molecules29235618

N/A

0DataRank · unranked

8 citations

Ming Cheng, Alina Ali, Jacqueline Lesperance, Dina V. Hingorani, Mike M. Allevato +7 more

Trends and Outcomes in Sarcomatoid Renal Cell Carcinoma: Analysis of the National Cancer Data Base

European Urology Open Science(2024)10.1016/j.euros.2024.10.002

N/A

0DataRank · unranked

4 citations

Dhruv Puri, Cesare Saitta, Franklin Liu, Jonathan Afari, Margaret F. Meagher +9 more

Comparison of outcomes of radical and partial nephrectomy for sarcomatoid renal cell carcinoma: analysis of the national cancer database

World Journal of Urology(2024)10.1007/s00345-024-05169-w

N/A

0DataRank · unranked

3 citations

Kit L. Yuen, Cesare Saitta, Margaret F. Meagher, Franklin Liu, Melis Güer +6 more

The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study

Cancer(2024)10.1002/cncr.35247

N/A

0DataRank · unranked

3 citations

Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R. K. Singh +52 more

Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.04.003

N/A

0DataRank · unranked

3 citations

Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang, Joy Awosika +27 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509

N/A

0DataRank · unranked

15 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapies

npj Precision Oncology(2025)10.1038/s41698-025-00885-x

N/A

0DataRank · unranked

12 citations

Stephen Adams, Rana R. McKay, Zhiyong Wang, Sunil J. Advani, Mahsa Mortaja

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Nature Communications(2025)10.1038/s41467-025-64153-z

N/A

0DataRank · unranked

8 citations

Marina N. Sharifi, Jamie M. Sperger, Matthew R. Chrostek, Matthew L. Bootsma, Shannon R. Reese +22 more

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3471

N/A

0DataRank · unranked

11 citations

Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye +18 more

The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer

Cancers(2025)10.3390/cancers17081270

N/A

0DataRank · unranked

1 citations

Allison Makovec, Carly D. Miller, Shayan Nazari, Andrew Elliott, Aiden Deacon +10 more

Circulating tumor cell (CTC) expression patterns of cell surface targets in metastatic prostate cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.232

N/A

0DataRank · unranked

1 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, Kyle T. Helzer +10 more

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101038

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Sanjay Mishra, Elizabeth A. Griffiths, Brahm H. Segal, Clara Hwang +30 more

Obesity’s Disparate Impact on COVID-19 Outcomes in Asian American Patients with Cancer

medRxiv(2025)10.1101/2025.05.14.25327577

N/A

0DataRank · unranked

0 citations

Pankil Shah, Sanjay Mishra, Julie Fu, Sonya Reid, Jessica E. Hawley +18 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

UNC Libraries(2025)10.17615/bna9-v350

N/A

0DataRank · unranked

0 citations

Sanjay Mishra, Karen Russell, Samuel M. Rubinstein, Blau, Sibel, Daniel Y. Reuben +39 more

Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey‐Holden Prostate Cancer Academy Meeting

The Prostate(2025)10.1002/pros.70102

N/A

0DataRank · unranked

0 citations

Saul J. Priceman, Ashley E. Ross, Phuoc T. Tran, Rana R. McKay, Kenneth J. Pienta +3 more

Rana R. McKay

Indexed papers

Top data-sharing exemplar

Papers